Gastroenterology

Gastroenterology

Volume 110, Issue 1, January 1996, Pages 221-226
Gastroenterology

Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer

https://doi.org/10.1053/gast.1996.v110.pm8536860Get rights and content

Abstract

BACKGROUND & AIMS: Point mutations of the Ki-ras gene at codon 12 have been frequently identified in pure pancreatic juice of patients with pancreatic cancer in studies examining pancreatic cancer tissues. The aim of this study was to examine mutations of the Ki-ras codon 12 in the duodenal juice collected from patients with various pancreatic disorders. METHODS: The duodenal juice was collected through a Dreiling tube installed in the duodenum during a secretin test. Analysis of the Ki-ras mutations was performed using the enriched polymerase chain reaction--single-strand conformation polymorphism technique. RESULTS: Point mutations were detected in 12 of 19 patients with pancreatic cancer; of the 12 patients, 10 had ductal tubular adenocarcinoma and 2 intraductal papillary adenocarcinoma. Mutational patterns included GAT (n = 4), GTT (n = 3), CGT (n = 1), and double mutations of GTT and GAT (n = 3) and GAT and CGT (n = 1). In 41 patients with benign pancreatic disorders, a point mutation was detected in only 1 patient with chronic pancreatitis. CONCLUSIONS: Analysis of the Ki-ras codon 12 mutations in the duodenal juice is useful in the diagnosis of pancreatic cancer. (Gastroenterology 1996 Jan;110(1):221-6)

References (0)

Cited by (106)

  • Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer

    2022, Pancreatology
    Citation Excerpt :

    The initial search identified 580 studies, of which 504 were excluded based on title and abstract. After full-text review, 41 studies were included: 32 concerning DNA mutations, 14 DNA methylations and five describing both [12–52] (Fig. 1). For each study, distinct collection methods and DNA analysis methods were reported.

  • Endoscopic Retrograde Cholangiopancreatography Tissue Sampling: When and How?

    2007, Clinical Gastroenterology and Hepatology
    Citation Excerpt :

    On the basis of our experience with cytology and these ancillary techniques, an algorithmic approach26 has been developed (Figure 8). Other ancillary tools that have been tested and found possibly helpful include immunohistochemical staining for p53,35,36 flow cytometry,37 polymerase chain reaction for mutations in codon 12 of the k-ras gene,38 loss of heterozygosity,39 and real-time reverse transcription polymerase chain reaction for specific mRNAs.40 None of these techniques is in everyday clinical use.

  • Detection of oncogenes in chronic pancreatitis

    2003, HPB
    Citation Excerpt :

    The analysis of gene mutations and gene expression in pancreatic cancer and CP has identified several factors, which are commonly deregulated in both diseases [54–57]. Detection of mutations in the K‐ras proto‐oncogene and p53 tumour suppressor gene in specimens obtained by needle aspiration, from pure pancreatic juice, duodenal juice, serum or stool, may be clinically useful diagnostic markers for early detection of pancreatic malignancy [58–70]. Although these mutations are considered critical and early events in pancreatic oncogenesis, the role of K‐ras and p53 mutations in CP as a precancerous disorder is not completely known.

  • Pancreatic Cancer

    2021, Cancer Screening: Theory and Practice
View all citing articles on Scopus
View full text